Enveric Biosciences Showcases Breakthrough Neuroplastogenic Therapies at Canadian Chemical Engineering Conference

Published | Modified November 24, 2023
CSIMarket Newsroom | CSIMarket.com

Enveric Biosciences, a leading biotechnology company focused on groundbreaking neuroplastogenic small-molecule therapeutics, recently made waves at the Canadian Chemical Engineering Conference (CSChE 2023). The company unveiled two groundbreaking posters that emphasized their commitment to developing innovative solutions for depression, anxiety, and addiction disorders.

The first poster

Source for this article: Based on ’s official statement

For details on how CSIMarket validates financial and corporate news, please review our Editorial Standards & Fact-Checking Policy .

Comments

Comments are available to active subscribers. Subscribe or Log in.

Get the full CSIMarket dataset: Subscribe API License